Brief: Celltrion Wins Sales Approval Recommendation For Its CT-P16 From European Medicines Agency's Committee
27/06/2022 24:34
June 27 (Reuters) - Celltrion Inc 068270.KS :
* WINS SALES APPROVAL RECOMMENDATION FOR ITS CT-P16 FROM
EUROPEAN
MEDICINES AGENCY'S COMMITTEE
Further company coverage: 068270.KS
(Reporting by ByungwookKim Kim)
((Byungwook.Kim@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion, Q3 Operating. Profit 510 Billion Won, Up 69% Y/Y
Brief: Celltrion, To Buy 100 Billion Won Worth Of Own Shares
Brief: Celltrion Sets Mid-To-Long Term Shareholder Return Target To One-Third Of Net Profit
South Korean chip stocks rally, tracking US AI gains; Temasek report adds support
Brief: Celltrion Q2 Operating Profit Rises 77.3% Y/Y To 430 Billion Won